Day: September 4, 2020

SAN JOSE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today positive results from a successfully completed a multi-year lung cancer prognosis and recurrence study in collaboration with a major hospital in China. The clinical study began in 2014, with the enrollment and completed all follow-up and testing in 2020. Approximately 1,000 confirmed lung cancer patients were tested in the clinical study using AnPac Bio’s cancer differentiation analysis (CDA) technology for prognosis and recurrence utility evaluations throughout initial diagnosis, surgery, chemotherapy and other treatments, and remission (for recurrence monitoring).Initial results from the study indicate...

Stéphane Therrien, Interim President and Chief Executive Officer, commented on the third quarter of 2020 highlights: “From the onset of the pandemic, we have taken measures to preserve the financial strength and stability of the Bank. Capital and liquidity have always been managed prudently and continue to be during these uncertain times. Our track record on the credit front is solid and is supported by our rigorous underwriting.”  “We continued to support our customers with numerous programs, including payment deferrals. With the economy gradually re-opening and individuals and businesses adjusting to the new realities, many customers who requested deferrals at the beginning of the pandemic have since resumed payments.”  M. Therrien concluded: “As we navigate through these challenging times, we have never lost sight...

Stéphane Therrien, président et chef de la direction par intérim, a fait les commentaires suivants sur les faits saillants du troisième trimestre 2020 : « Dès le début de la pandémie, nous avons pris des mesures pour préserver la solidité et la stabilité financières de la Banque. Le capital et les liquidités ont toujours été gérés avec prudence et continuent de l’être en ces temps incertains. Notre bilan au niveau du crédit est solide et est soutenu par nos pratiques de souscription rigoureuses  ».« Nous avons continué à soutenir nos clients grâce à de nombreux programmes, notamment de report de paiement. Avec la réouverture progressive de l’économie et l’adaptation des particuliers et des entreprises aux nouvelles réalités, de nombreux clients qui avaient demandé un report de paiement au début de la pandémie ont depuis...

HOUSTON, Sept. 04, 2020 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE:AROC) (“Archrock”) today announced that Brad Childers, President and Chief Executive Officer, will host meetings with investors at the Barclays CEO Energy-Power Conference on September 9, 2020.In addition, Doug Aron, Chief Financial Officer, will present at the 9th Annual Gateway Conference on September 10, 2020, at 4:30 p.m. Central Time, with one-on-one meetings held throughout the conference. The webcast link and slides will be available prior to the commencement of the meetings under the “Investors” tab of our website, www.archrock.com. A replay of the webcast will be available following the live event.About ArchrockArchrock is an energy infrastructure company with a pure-play focus on midstream natural gas compression.  Archrock is the leading provider of natural...

BOSTON, Sept. 04, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that Jason Robins, co-founder, Chief Executive Officer and Chairman of the Board, will participate in the following investor and industry conferences:The SBC Summit on September 8, 2020. The presentation is scheduled for 4:00AM ET.The Goldman Sachs Investment Banking and Equity Capital Markets “SPACs: What You Need To Know” on September 9, 2020. The presentation is scheduled for 3:35PM ET.The Bank of America 2020 Gaming and Lodging Conference on September 17, 2020. The presentation is scheduled for 11:20AM ET.The audio portions of the SBC, Goldman Sachs and Bank of America presentations will be webcast live over the internet and can be accessed at investors.draftkings.com.About DraftKingsDraftKings Inc. (Nasdaq: DKNG) is a digital sports entertainment...

HRC WORLD PLCNASDAQ FIRST NORTH, COPENHAGENTICKER: HRCISIN: GB00BZ3CDY204 September 2020RESULTS OF ANNUAL GENERAL MEETINGThe Board of Directors of HRC World Plc (“HRC” or the “Company” or the “Group”), are pleased to announce that its Annual General Meeting (“AGM”) was held in Kuala Lumpur earlier today, 4 September 2020. Details of the resolutions to be considered at the AGM were published in the Notice of AGM on 13 August 2020, which is available on the Company’s website at http://www.hrcplc.co.uk.AGM resolved among others to receive and approve the Company’s Audited Financial Statements, together with the Reports of the Directors and the Auditor, for period ended 31 March 2020. Further all directors of the Company consisting of (a) Shailen Popatlal (b) Simon Retter and (c) Dr. Md Khussairiee Ahmad retired and stood...

COPENHAGEN, Denmark, Sept. 04, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced two presentations for its TransCon PTH program in adult hypoparathyroidism (HP) at the 22nd European Congress of Endocrinology (e-ECE) 2020, taking place online September 5–9, 2020.“Our presentation of the randomized, double-blind phase 2 PaTH Forward Trial data at this year’s ECE support the use of TransCon PTH as a potential hormone replacement therapy for people living with HP,” said Aimee Shu, M.D., Senior Medical Director, Clinical Development at Ascendis Pharma. ”We are impressed by the phase 2 results which demonstrated that after only four weeks in a fixed-dose regimen, 82 percent of subjects were able to discontinue...

WOBURN, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present a scientific poster at the PAINWeek 2020 Live Virtual Conference to be held September 11 – 13.  PAINWeek is the preferred resource in the U.S. for frontline practitioners treating acute and chronic pain.The poster is titled “Real-World Outcomes from High-Dose Transcutaneous Electrical Nerve Stimulation in Individuals With Chronic Knee Pain”.  The poster presents an analysis of 1,136 Quell® users with chronic knee pain who used their device regularly over the first 70 days following initiation of therapy.  A key strength of this longitudinal observational study was the use of an intention-to-treat analysis to decrease bias. The study demonstrated a clinically meaningful group mean improvement in...

LEXINGTON, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) continued the New Technology Add-on Payment (NTAP) for the Company’s T2Bacteria® Panel for Fiscal Year 2021.With this extension, U.S. hospitals treating Medicare inpatients with sepsis continue to be eligible for a NTAP of $97.50 for the T2Bacteria Panel. This accounts for an additional 65 percent of the average price of the T2Bacteria Panel, to be paid along with the diagnosis-related group (MS-DRG) reimbursement that hospitals receive under the Medicare Hospital Inpatient Prospective Payment System (IPPS) for cases exceeding the MS-DRG payment.“We are pleased with CMS’s decision to extend the NTAP for...

CAMBRIDGE, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the development of soluble guanylate cyclase (sGC) stimulators for the treatment of serious and orphan diseases, today announced that Company management will be participating in several upcoming September 2020 investor conferences:Citi’s 15th Annual BioPharma Virtual Conference on September 9thH.C. Wainwright & Co 22nd Annual Global Investment Conference on September 16th at 9:30 a.m. ETCantor Virtual Global Healthcare Conference on September 16th and a virtual Fireside Chat on September 17th at 3:20 p.m. ETOppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21st –23rd on September 21st at 10:50 a.m. ETA live webcast of the H.C. Wainwright, Cantor, and...